5 Einträge gefunden

1. First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial

   1. Paschold, Lisa
   2. Stein, Alexander
   3. Thiele, Benjamin
   4. Tintelnot, Joseph
   5. Henkes, Svenja-Sibylla
   6. Coith, Cornelia
   7. Schultheiß, Christoph

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial

   1. Stein, Alexander
   2. Paschold, Lisa
   3. Tintelnot, Joseph
   4. Goekkurt, Eray
   5. Henkes, Svenja-Sibylla
   6. Simnica, Donjete
   7. Schultheiss, Christoph

   2022 - Forschungsinformationssystem des UKE
3. A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

   1. Moehler, Markus
   2. Michel, Maurice
   3. Stein, Alexander
   4. Trojan, Joerg
   5. Marquardt, Jens
   6. Tintelnot, Joseph
   7. Waidmann, Oliver

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

   1. Stein, Alexander
   2. Simnica, Donjete
   3. Schultheiß, Christoph
   4. Scholz, Rebekka
   5. Tintelnot, Joseph
   6. Gökkurt, Eray
   7. von Wenserski, Lisa

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches

   1. Tintelnot, Joseph
   2. Stein, Alexander

   2019 - Forschungsinformationssystem des UKE